Shannon-Dorcy, Kathleen <br/><br/>
Nursing implications of mylotarg: a novel antibody-targeted chemotherapy for CD33+ acute myeloid leukemia in first relapse.  [electronic resource] 

 -  Oncology nursing forum  May 2002 
 - E52-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-0688 
<br/><br/><label>Standard No.: </label>10.1188/02.ONF.E52-E59  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Aminoglycosides<br/>Anti-Bacterial Agents--pharmacology<br/>Antibodies, Monoclonal--pharmacology<br/>Antigens, CD--analysis<br/>Antigens, Differentiation, Myelomonocytic--analysis<br/>Antineoplastic Agents--pharmacology<br/>Humans<br/>Leukemia, Myeloid--diagnosis<br/>Middle Aged<br/>Monitoring, Physiologic<br/>Patient Education as Topic<br/>Patient Selection<br/>Recurrence<br/>Sialic Acid Binding Ig-like Lectin 3